
    
      Detailed Description:

      This trial is a randomized, double-blind, placebo-controlled, parallel-group trial in
      subjects diagnosed with lateral epicondylitis (tennis elbow). Subjects entered into the trial
      will be assigned to one of four treatment groups. The total duration is up to 13 days of
      trial participation.
    
  